Continuum Advisory’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$608K Buy
1,930
+383
+25% +$121K 0.05% 264
2026
Q1
$508K Buy
1,547
+176
+13% +$63.2K 0.05% 280
2025
Q4
$482K Buy
1,371
+757
+123% +$276K 0.05% 285
2025
Q3
$227K Buy
+614
New +$237K 0.02% 405
2025
Q2
Sell
-532
Closed -$198K 1431
2025
Q1
$198K Buy
532
+29
+6% +$11K 0.03% 392
2024
Q4
$181K Buy
503
+47
+10% +$17.4K 0.02% 402
2024
Q3
$175K Buy
456
+345
+311% +$119K 0.02% 419
2024
Q2
$37.8K Sell
111
-7
-6% -$2.37K 0.01% 660
2024
Q1
$39K Buy
+118
New +$39.7K 0.01% 648

Other funds holding SYK

Continuum Advisory's SYK Position: Q2 2026 in Review

Continuum Advisory increased its Stryker (SYK) stake by 25% in Q2 2026, buying an estimated $121K and bringing the position to 1,930 shares worth $608K. The position accounts for 0.05% of the portfolio, ranked #264.

Continuum Advisory first reported a position in SYK in Q1 2024 and has held it in 9 quarters since. 2,260 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Continuum Advisory held 1,930 shares of Stryker worth $608K as of Q2 2026.
  • Continuum Advisory bought 383 Stryker shares in Q2 2026, an estimated $121K.
  • Stryker made up 0.05% of Continuum Advisory's portfolio in Q2 2026, its #264 holding.
  • Continuum Advisory first reported a position in Stryker in Q1 2024 and has held it in 9 quarters since.
  • 2,260 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.